AstraZeneca ‘very disappointed’ over axed £450m Liverpool vaccine project
As drugmaker reports 38% jump in profits Pascal Soriot denies ongoing tension with UK government over Speke plant decisionBusiness live – latest updatesAstraZeneca’s boss has broken its silence since ditching a £450m vaccine plant expansion in Liverpool a week ago, saying the drugmaker was “very disappointed” to have been unable to make a business case for the investment.Pascal Soriot told reporters on Thursday: “This is one of those cases and we see that regularly, where we could not make … the investment economically viable … We are all very disappointed but this is business life.” Continue reading...
As drugmaker reports 38% jump in profits Pascal Soriot denies ongoing tension with UK government over Speke plant decision
AstraZeneca’s boss has broken its silence since ditching a £450m vaccine plant expansion in Liverpool a week ago, saying the drugmaker was “very disappointed” to have been unable to make a business case for the investment.
Pascal Soriot told reporters on Thursday: “This is one of those cases and we see that regularly, where we could not make … the investment economically viable … We are all very disappointed but this is business life.” Continue reading...
